table of content
Table of Contents
Global Pharmacokinetics Services Market Segment Research Report 2022
1. Research Scope
2. Market Overview
2.1 Product Introduction, Application, Picture
2.2 Global Pharmacokinetics Services Market by Value
2.2.1 Global Pharmacokinetics Services Revenue by Type
2.2.2 Global Pharmacokinetics Services Market by Value
2.3 Global Pharmacokinetics Services Market by Sales
2.3.1 Global Pharmacokinetics Services Sales by Type
2.3.2 Global Pharmacokinetics Services Market by Sales
3. The Major Driver of Pharmacokinetics Services Industry
3.1 Historical & Forecast Global Pharmacokinetics Services Sales and Revenue (2018-2028)
3.2 Largest Application for Pharmacokinetics Services (2018-2028)
3.3 The Major Downstream Company in China Market 2022
4. Global and Regional Pharmacokinetics Services Market
4.1 Regional Market Size in Terms of Sales (2022 & 2028)
4.2 Regional Market Share in Terms of Revenue (2022 & 2028)
4.3 Concentration Ratio (CR5& CR10) of Pharmacokinetics Services Market
4.4 Mergers & Acquisitions, Expansion Plans
5. US Pharmacokinetics Services Sales (2018-2028)
5.1 Current and Estimated Sales Breakdown by Type (2018-2028)
5.2 Current and Estimated Sales Breakdown by Application (2018-2028)
5.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
5.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
6. Europe Pharmacokinetics Services Sales (2018-2028)
6.1 Current and Estimated Sales Breakdown by Type (2018-2028)
6.2 Current and Estimated Sales Breakdown by Application (2018-2028)
6.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
6.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
7. China Pharmacokinetics Services Sales (2018-2028)
7.1 Current and Estimated Sales Breakdown by Type (2018-2028)
7.2 Current and Estimated Sales Breakdown by Application (2018-2028)
7.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
7.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
8. Japan Pharmacokinetics Services Sales (2018-2028)
8.1 Current and Estimated Sales Breakdown by Type (2018-2028)
8.2 Current and Estimated Sales Breakdown by Application (2018-2028)
8.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
8.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
9. India Pharmacokinetics Services Sales (2018-2028)
9.1 Current and Estimated Sales Breakdown by Type (2018-2028)
9.2 Current and Estimated Sales Breakdown by Application (2018-2028)
9.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
9.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
10. Korea Pharmacokinetics Services Sales (2018-2028)
10.1 Current and Estimated Sales Breakdown by Type (2018-2028)
10.2 Current and Estimated Sales Breakdown by Application (2018-2028)
10.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
10.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
11. Southeast Asia Pharmacokinetics Services Sales (2018-2028)
11.1 Current and Estimated Sales Breakdown by Type (2018-2028)
11.2 Current and Estimated Sales Breakdown by Application (2018-2028)
11.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
11.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
12. South America Pharmacokinetics Services Sales (2018-2028)
12.1 Current and Estimated Sales Breakdown by Type (2018-2028)
12.2 Current and Estimated Sales Breakdown by Application (2018-2028)
12.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
12.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
13. Global Pharmacokinetics Services Average Price Trend
13.1 Market Price for Each Type of Pharmacokinetics Services in US (2018-2022)
13.2 Market Price for Each Type of Pharmacokinetics Services in Europe (2018-2022)
13.3 Market Price for Each Type of Pharmacokinetics Services in China (2018-2022)
13.4 Market Price for Each Type of Pharmacokinetics Services in Japan (2018-2022)
13.5 Market Price for Each Type of Pharmacokinetics Services in India (2018-2022)
13.6 Market Price for Each Type of Pharmacokinetics Services in Korea (2018-2022)
13.7 Market Price for Each Type of Pharmacokinetics Services in Southeast Asia (2018-2022)
13.8 Market Price for Each Type of Pharmacokinetics Services in South America (2018-2022)
14. Industrial Chain (Impact of COVID-19)
14.1 Pharmacokinetics Services Industrial Chain Analysis
14.2 Downstream
14.3 Impact of COVID-19
14.4 Post-pandemic Era
14.5 Technology Trends of Pharmacokinetics Services
15. Pharmacokinetics Services Competitive Landscape
15.1 Evotec AG (Germany)
15.1.1 Evotec AG (Germany) Company Profiles
15.1.2 Evotec AG (Germany) Product Introduction
15.1.3 Evotec AG (Germany) Pharmacokinetics Services Sales, Revenue (2018-2022)
15.1.4 Strategic initiatives
15.2 Pacific BioLabs (US)
15.2.1 Pacific BioLabs (US) Company Profiles
15.2.2 Pacific BioLabs (US) Product Introduction
15.2.3 Pacific BioLabs (US) Pharmacokinetics Services Sales, Revenue (2018-2022)
15.2.4 Strategic initiatives
15.3 GVK Biosciences Private Limited (India)
15.3.1 GVK Biosciences Private Limited (India) Company Profiles
15.3.2 GVK Biosciences Private Limited (India) Product Introduction
15.3.3 GVK Biosciences Private Limited (India) Pharmacokinetics Services Sales, Revenue (2018-2022)
15.3.4 Strategic initiatives
15.4 Shanghai Medicilon Inc. (China)
15.4.1 Shanghai Medicilon Inc. (China) Company Profiles
15.4.2 Shanghai Medicilon Inc. (China) Product Introduction
15.4.3 Shanghai Medicilon Inc. (China) Pharmacokinetics Services Sales, Revenue (2018-2022)
15.4.4 Strategic initiatives
15.5 Pharmaceutical Product Development, LLC (US)
15.5.1 Pharmaceutical Product Development, LLC (US) Company Profiles
15.5.2 Pharmaceutical Product Development, LLC (US) Product Introduction
15.5.3 Pharmaceutical Product Development, LLC (US) Pharmacokinetics Services Sales, Revenue (2018-2022)
15.5.4 Strategic initiatives
15.6 Charles River Laboratories International, Inc. (US)
15.6.1 Charles River Laboratories International, Inc. (US) Company Profiles
15.6.2 Charles River Laboratories International, Inc. (US) Product Introduction
15.6.3 Charles River Laboratories International, Inc. (US) Pharmacokinetics Services Sales, Revenue (2018-2022)
15.6.4 Strategic initiatives
15.7 PAREXEL International Corporation (US)
15.7.1 PAREXEL International Corporation (US) Company Profiles
15.7.2 PAREXEL International Corporation (US) Product Introduction
15.7.3 PAREXEL International Corporation (US) Pharmacokinetics Services Sales, Revenue (2018-2022)
15.7.4 Strategic initiatives
15.8 Eurofins Scientific, Inc. (Luxembourg)
15.8.1 Eurofins Scientific, Inc. (Luxembourg) Company Profiles
15.8.2 Eurofins Scientific, Inc. (Luxembourg) Product Introduction
15.8.3 Eurofins Scientific, Inc. (Luxembourg) Pharmacokinetics Services Sales, Revenue (2018-2022)
15.8.4 Strategic initiatives
15.9 Frontage Labs (US)
15.9.1 Frontage Labs (US) Company Profiles
15.9.2 Frontage Labs (US) Product Introduction
15.9.3 Frontage Labs (US) Pharmacokinetics Services Sales, Revenue (2018-2022)
15.9.4 Strategic initiatives
15.10 SGS SA (Switzerland)
15.10.1 SGS SA (Switzerland) Company Profiles
15.10.2 SGS SA (Switzerland) Product Introduction
15.10.3 SGS SA (Switzerland) Pharmacokinetics Services Sales, Revenue (2018-2022)
15.10.4 Strategic initiatives
15.11 LGC Limited (UK)
15.12 Creative Bioarray (US)
15.13 Certara, L.P. (Germany)
16. Conclusion
17. Methodology and Data Source
